XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.3
MERGER (Tables)
 9 Months Ended
Sep. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS AND LIABILITIES ASSUMED BASED ON THEIR ESTIMATED FAIR VALUES

Purchase price:    
Common Stock and Pre-Funded Warrants consideration  $179 
Series X Preferred Stock consideration   41,685 
Total purchase price  $41,864 
      
Allocated tangible assets:     
Net working capital  $(3,198)
Inventory   395 
Property and equipment   112 
Right-of-use assets   58 
Lease liability   (14)
Total allocated tangible assets  $(2,647)
      
Purchase price allocated to intangible assets     
Tradename and trademarks  $560 
Proprietary technology   3,500 
Customer relationships   1,820 
Goodwill (unallocated intangible value)  $38,631 
SCHEDULE OF SUPPLEMENTAL CONSOLIDATED FINANCIAL RESULT OF THE COMPANY

Following are the supplemental consolidated financial results of the Company, NanoVibronix and ENvue on an unaudited pro forma basis, as if the acquisitions had been consummated as of the beginning of the fiscal year 2025 (i.e., January 1, 2025).

 

   Nine Months Ended 
   September 30, 2025 
Net revenue  $2,296 
Net loss  $(5,113)